SEC 13F Intelligence

Parkman Healthcare Partners LLC / HQ8F

Parkman Healthcare Partners LLC’s Apollo Endosurgery Inc Position

Does Parkman Healthcare Partners LLC own Apollo Endosurgery Inc (HQ8F)? Not currently — the last reported position was 657.7K shares worth $4M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2022
Shares
657.7K
% of Portfolio
+1.03%
Quarters Held
7
position exited

Position History HQ8F

Reported value by quarter
Q1 ’21: $413,000Q1 ’21Q2 ’21: $6MQ2 ’21Q3 ’21: $8MQ3 ’21Q4 ’21: $8MQ4 ’21Q1 ’22: $5MQ1 ’22Q2 ’22: $2MQ2 ’22Q3 ’22: $4MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022657.7K$4M+1.03%
Q2 2022650.0K$2M+0.87%
Q1 2022810.4K$5M+1.43%
Q4 2021918.5K$8M+1.71%
Q3 2021831.2K$8M+1.91%
Q2 2021691.2K$6M+1.22%
Q1 202175.0K$413,000+0.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of HQ8F.